[go: up one dir, main page]

PE20061394A1 - Metabolitos de n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-5-tiazolcarboxamidas - Google Patents

Metabolitos de n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-5-tiazolcarboxamidas

Info

Publication number
PE20061394A1
PE20061394A1 PE2006000282A PE2006000282A PE20061394A1 PE 20061394 A1 PE20061394 A1 PE 20061394A1 PE 2006000282 A PE2006000282 A PE 2006000282A PE 2006000282 A PE2006000282 A PE 2006000282A PE 20061394 A1 PE20061394 A1 PE 20061394A1
Authority
PE
Peru
Prior art keywords
piperazinyl
pyrimidinyl
metabolites
methylphenyl
hydroxyethyl
Prior art date
Application number
PE2006000282A
Other languages
English (en)
Inventor
Vinod Kumar Arora
Lisa Joy Christopher
Donghui Cui
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PE20061394A1 publication Critical patent/PE20061394A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

REFERIDA A UN METABOLITO DE 'N-(2-CLORO-6-METILFENIL)-2-[[6-[4-(2-HIDROXIETIL)-1-PIPERAZINIL]-2-METIL-4-PIRIMIDINIL]AMINO]-5-TIAZOLCARBOXAMIDA DE FORMULA (I). TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS METABOLITOS SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES ONCOLOGICAS
PE2006000282A 2005-03-15 2006-03-13 Metabolitos de n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-5-tiazolcarboxamidas PE20061394A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66177705P 2005-03-15 2005-03-15
US72873205P 2005-10-20 2005-10-20

Publications (1)

Publication Number Publication Date
PE20061394A1 true PE20061394A1 (es) 2006-12-15

Family

ID=36603642

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000282A PE20061394A1 (es) 2005-03-15 2006-03-13 Metabolitos de n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-5-tiazolcarboxamidas

Country Status (6)

Country Link
US (1) US7622473B2 (es)
EP (1) EP1863807A1 (es)
AR (1) AR053169A1 (es)
PE (1) PE20061394A1 (es)
TW (1) TW200700416A (es)
WO (1) WO2006099474A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2207777A2 (en) * 2007-10-23 2010-07-21 Teva Pharmaceutical Industries Ltd. Polymorphs of dasatinib and process for preparation thereof
EP2222166B9 (en) * 2007-12-10 2012-11-07 Concert Pharmaceuticals Inc. Heterocyclic kinase inhibitors
BRPI0800951A2 (pt) * 2008-04-09 2012-02-22 Ems Sa novos compostos derivados de taurina e seus usos, processo de sua preparação e composições farmacêuticas contendo os mesmos
WO2010010914A1 (ja) * 2008-07-23 2010-01-28 オリンパス株式会社 糞便試料からの核酸回収方法、核酸解析方法及び糞便試料処理装置
CN101973989B (zh) * 2010-05-17 2012-07-18 苏州波锐生物医药科技有限公司 一种噻唑酰胺类化合物及其在治疗恶性肿瘤中的药物用途
WO2012129381A1 (en) 2011-03-22 2012-09-27 Concert Pharmaceuticals Inc. Deuterated preladenant
CN103172627B (zh) * 2011-12-26 2015-11-18 南京优科生物医药有限公司 杂环嘧啶苯或吡啶苯类化合物及其应用
GB2508652A (en) * 2012-12-07 2014-06-11 Agency Science Tech & Res Heterocyclic piperazine derivatives
CN103012395B (zh) * 2013-01-04 2015-05-13 南京优科生物医药有限公司 一种杂环嘧啶苯类化合物的制备方法
CN104151321B (zh) * 2013-05-15 2016-09-07 复旦大学 N-(2-氯-6-甲基苯基)-2[(2-甲基嘧啶-4-基)氨基]噻唑-5-甲酰胺化合物及其制备方法和用途
CN103319476B (zh) * 2013-06-13 2015-12-02 济南德爱医药技术有限公司 一种激酶抑制剂
CN105503852B (zh) * 2014-09-26 2018-06-22 山东新时代药业有限公司 噻唑甲酰胺氮氧化物
CN106279143A (zh) * 2015-05-11 2017-01-04 天津国际生物医药联合研究院 噻唑杂环类化合物及其制备方法和应用
US20180099961A1 (en) 2016-12-13 2018-04-12 Princeton Drug Discovery Inc Protein kinase inhibitors
CN115192540A (zh) 2018-06-15 2022-10-18 汉达癌症医药责任有限公司 激酶抑制剂的盐类及其组合物
CN112402422A (zh) * 2019-08-20 2021-02-26 湖南华纳大药厂股份有限公司 氟取代的2-氨基噻唑-5-芳香族甲酰胺的用途
CN112409349A (zh) * 2019-08-20 2021-02-26 湖南华纳大药厂股份有限公司 激酶抑制剂及其制备、药物组合物和用途
CN119841819A (zh) * 2023-10-16 2025-04-18 北京大学 靶向bcr-abl的降解剂及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7125875B2 (en) 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
HUP0202708A3 (en) 1999-04-15 2004-12-28 Bristol Myers Squibb Co Cyclic protein tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use
US20050009891A1 (en) 2003-07-09 2005-01-13 Lee Francis Y. Combination of SRC Kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
US20060069101A1 (en) * 2004-09-27 2006-03-30 Kim Kyoung S Prodrugs of protein tyrosine kinase inhibitors
AU2006209183B2 (en) * 2005-01-26 2009-11-19 Irm Llc Compounds and compositions as protein kinase inhibitors

Also Published As

Publication number Publication date
WO2006099474A1 (en) 2006-09-21
US20060211705A1 (en) 2006-09-21
TW200700416A (en) 2007-01-01
AR053169A1 (es) 2007-04-25
US7622473B2 (en) 2009-11-24
EP1863807A1 (en) 2007-12-12

Similar Documents

Publication Publication Date Title
PE20061394A1 (es) Metabolitos de n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-5-tiazolcarboxamidas
NO20075154L (no) Formuleringer av en src/abl-inhibitor
PE20110062A1 (es) N-(3-(3,5-dimetoxifenetil)-1h-pirazol-5-il)-4-(3,4-dimetilpiperazin-1-il)benzamida y sales del mismo
NO20091892L (no) Krystallinsk form av (3S)-3-(N-(N`-(2-tert-butylfenyl)oksamyl) alaninyl)amino-5-(2`,3`,5`,6`-tetrafluorfenoksy)-4 oksopentanoisk syre
PE20091201A1 (es) AMIDAS SUSTITUIDAS COMO INHIBIDORES DE LA TIROSINA QUINASA DE BRUTON (Btk)
PE20141700A1 (es) Compuestos de 2-(2,4,5-anilino sustituido) pirimidina
PE20071061A1 (es) Derivados de carbonilo como inhibidores de peptidil-deformilasa (pdf)
UY28885A1 (es) 4-fenilamino-quinazolin-6-il-amidas referencia cruzada a solicitud(es) relacionada(s)
ATE517874T1 (de) Pyrimidinone als modulatoren von caseinkinase ii (ck2)
CL2007002930A1 (es) Un compuesto 4-[4-({[4-cloro-3-(trifluorometil)fenil]carbamoil}amino)-3-fluorofenoxi]-n-metilpiridin-2-carboxamida monohidratado; proceso de preparacion; composicion y combinacion farmaceutica; y uso para el tratamiento de trastornos hiperproliferati
PE20090210A1 (es) Compuestos derivados de pirazolo pirimidina como inhibidores de jak quinasa
DE602004028150D1 (de) Aminopyrazolderivate als gsk-3-inhibitoren
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
NO20075087L (no) Kombinasjoner, metoder og sammensetninger for behandling av cancer
UY31463A1 (es) Inhibidores de péptido desformilasa
TW200700392A (en) Novel compounds
DE602006004865D1 (de) Antimykotische mittel
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
BR0313385A (pt) Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz
GT200600105A (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos.
CY1112718T1 (el) Ν- (2-υδροξυαιθυλ) -ν-μεθυλ-4- (κινολιν-8-υλ (1- (θειαζολ-4-υλμεθυλ) πιπεριδιν- 4 -υλιδενο) μεθυλ) βενζαμιδιο, η μεθοδος παρασκευης του καθως και η χρηση του για τη θεραπευτικη αγωγη πονου, αγχους και καταθλιψης
DE602006005640D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
ATE469134T1 (de) Pharmazeutisch aktive diazepane
EA200701813A1 (ru) Новые амидозамещенные 6-фенилфенантридины
PE20080279A1 (es) DERIVADOS DE PIRAZOL[4,3-d]TIAZOL COMO INHIBIDORES DE LA PROTEINA QUINASA AURORA 1 Y 2

Legal Events

Date Code Title Description
FC Refusal